SCHEMBL19688313

SCHEMBL19688313

CCOC(=O)CC(=O)N(c1cccc(C(F)(F)F)c1)N(C)C=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.43
THRB P10828 1/20 0.41
HPGD P15428 2/20 0.41
HTT P42858 1/20 0.41
ALDH1A1 P00352 3/20 0.40
MAPT P10636 2/20 0.40
TP53 P04637 1/20 0.39
GAA P10253 2/20 0.39
ALOX12 P18054 2/20 0.39
F2 P00734 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TRPV4 Q9HBA0 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39
ATM Q13315 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LTB4R2 Q9NPC1 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19639758 0.85 ALOX15 (0.44) ALOX15THRBHPGDHTTALDH1A1
SCHEMBL19688780 0.78 ALOX15 (0.42) ALOX15THRBHPGDHTTALDH1A1
SCHEMBL20322937 0.77 ALOX15 (0.51) ALOX15THRBHPGDHTTALDH1A1
SCHEMBL9357893 0.74 LMNA (0.57) ALOX15THRBHPGDHTTALDH1A1
SCHEMBL1423257 0.71 ALDH1A1 (0.55) THRBHTTALDH1A1GAAF2
SCHEMBL5845058 0.70 ALOX15 (0.43) ALOX15THRBHPGDHTTALDH1A1
SCHEMBL798803 0.70 TSHR (0.54) ALOX15THRBHPGDHTTALDH1A1
SCHEMBL28787504 0.70 PRKCA (0.56) THRBHPGDHTTALDH1A1MAPT
SCHEMBL18700509 0.70 LTB4R2 (0.48) ALOX15THRBHPGDHTTALDH1A1
SCHEMBL333191 0.69 SMN1; SMN2 (0.65) HTTALDH1A1MAPTTP53GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017207433-A9 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF A DISEASE IN WHICH HNE IS IMPLICATED CHIESI FARMACEUTICI S.P.A. (IT) 2018-03-01 WO disclosed
WO-2017207433-A1 HETETOCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF A DISEASE IN WHICH HNE IS IMPLICATED CHIESI FARMACEUTICI S.P.A. (IT) 2017-12-07 WO disclosed